🇺🇸 FDA
Pipeline program

BXCL501 Sublingual Film

BXCL501-402

Phase 2 small_molecule completed

Quick answer

BXCL501 Sublingual Film for Bipolar I Disorder is a Phase 2 program (small_molecule) at BioXcel Therapeutics with 1 ClinicalTrials.gov record(s).

Program details

Company
BioXcel Therapeutics
Indication
Bipolar I Disorder
Phase
Phase 2
Modality
small_molecule
Status
completed

Clinical trials